SCHEMBL7163161

SCHEMBL7163161

CCOc1ccc(S(=O)(=O)N2CCNCC2)cc1-c1nc2c(OC)cccc2c(=O)[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.64
PDE2A O00408 1/20 0.54
ABCC4 O15439 1/20 0.54
ABCC5 O15440 1/20 0.54
PDE6D O43924 1/20 0.54
PDE8A O60658 1/20 0.54
PDE9A O76083 1/20 0.54
ABCB11 O95342 1/20 0.54
CYP3A4 P08684 1/20 0.54
HTR1A P08908 1/20 0.54
PDE6A P16499 1/20 0.54
PDE6G P18545 1/20 0.54
PDE4A P27815 1/20 0.54
ADORA2A P29274 1/20 0.54
ADORA1 P30542 1/20 0.54
ADRA1A P35348 1/20 0.54
PDE6B P35913 1/20 0.54
PDE6C P51160 1/20 0.54
PDE1A P54750 1/20 0.54
PDE1B Q01064 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9277180 0.91 PDE5A (0.64) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL7168287 0.88 PDE5A (0.67) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL7163148 0.80 PDE5A (0.60) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL7721640 0.79 PDE5A (0.69) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL25118239 0.79 PDE5A (0.88) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL3835985 0.79 PDE5A (0.68) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL7725915 0.78 PDE5A (0.62) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL30199797 0.78 PDE5A (1.00) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL1141 0.78 PDE5A (1.00) PDE5APDE2AABCC4ABCC5PDE6D
SCHEMBL9021637 0.77 PDE5A (0.86) PDE5APDE2AABCC4ABCC5PDE6D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562830-B1 Compounds which prevent or induce the remission of existing precancerous or cancerous lesions or carcinomas would greatly reduce illness and death from cancer CELL PATHWAYS, INC. 2003-05-13 US disclosed
EP-0628032-B1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LTD (GB) 1998-05-13 EP disclosed
WO-1993012095-A1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LIMITED (GB) 1993-06-24 WO disclosed